Posted On: 08/15/2016 12:51:57 PM
Post# of 145212
$ARTH .65! Huge clinical study news out today! Was at almost $1 last month!
Corporate Overview:
Bleeding and leakage remain compelling problems to solve. Patients matter.
The AC5 Surgical Hemostatic Device™ value proposition is based on the premise of faster and safer surgery. The product is designed to be simple (user-friendly), effective (works promptly), versatile (useful in challenging situations such as laparoscopic surgery**), and safe. These claims alongside the multipurpose nature of AC5™ distinguish it from first-generation solutions currently in use.
Large markets filled with problem products
In 2012, annual worldwide sales were over $2.8B for hemostatic agents and nearly $1.3B for fibrin and other sealants, which seal other leaks (cerebrospinal fluid, pleural, etc.). These products are anticipated to surpass global combined sales of over $7B in 2017.
Today's News: Clinical Safety and Performance of AC5 Successfully Demonstrated in Dermatology Procedure Performed on 46 Skin Lesion Patients With Bleeding Wounds
http://finance.yahoo.com/news/arch-therapeuti...00951.html
Corporate Overview:
Bleeding and leakage remain compelling problems to solve. Patients matter.
The AC5 Surgical Hemostatic Device™ value proposition is based on the premise of faster and safer surgery. The product is designed to be simple (user-friendly), effective (works promptly), versatile (useful in challenging situations such as laparoscopic surgery**), and safe. These claims alongside the multipurpose nature of AC5™ distinguish it from first-generation solutions currently in use.
Large markets filled with problem products
In 2012, annual worldwide sales were over $2.8B for hemostatic agents and nearly $1.3B for fibrin and other sealants, which seal other leaks (cerebrospinal fluid, pleural, etc.). These products are anticipated to surpass global combined sales of over $7B in 2017.
Today's News: Clinical Safety and Performance of AC5 Successfully Demonstrated in Dermatology Procedure Performed on 46 Skin Lesion Patients With Bleeding Wounds
http://finance.yahoo.com/news/arch-therapeuti...00951.html
(0)
(0)
